Norgine finally wins NICE nod for Targaxan
This article was originally published in Scrip
Executive Summary
Dutch specialty company Norgine has finally convinced NICE to recommend its hepatic encephalopathy drug Targaxan (rifaximin) for use on the NHS in England and Wales.